Breaking News Instant updates and real-time market news.

VLKAY

Volkswagen

$33.62

0.455 (1.37%)

, C

Citi

$66.72

-0.3 (-0.45%)

08:38
07/17/17
07/17
08:38
07/17/17
08:38

Volkswagen considers options for transmissions maker Renk, Reuters says

Volkswagen (VLKAY) is working with Citi (C) to consider options for transmissions maker Renk, which could include a sale, as the company seeks to streamline operations after its emissions scandal, Reuters reports, citing people familiar with the matter. A potential sale, which could begin as early as autumn, may attract private equity groups such as KKR (KKR), CVC, Cinven, Carlyle Group (CG) and Advent as well as Renk peers and Japanese groups such as Sumitomo Heavy, Kawasaki (KWHIY) and Mitsubishi (MTU), and the company may be valued at EUR600M-EUR800M, or $687M-$916M. Reference Link

VLKAY

Volkswagen

$33.62

0.455 (1.37%)

C

Citi

$66.72

-0.3 (-0.45%)

KKR

KKR

$19.25

0.09 (0.47%)

CG

Carlyle Group

$20.40

0.15 (0.74%)

KWHIY

Kawasaki Heavy Industries

MTU

Mitsubishi UFJ

$6.40

-0.09 (-1.39%)

  • 20

    Jul

  • 25

    Jul

  • 27

    Jul

VLKAY Volkswagen
$33.62

0.455 (1.37%)

02/13/17
WELS
02/13/17
NO CHANGE
WELS
Outperform
Mobileye could add to competitive advantage with VW deal, says Wells Fargo
Wells Fargo analyst Richard Kwas said that while Volkswagen (VLKAY) was expected to be announced as a customer of Mobileye's (MBLY) Road Experience Management system, the confirmation of an agreement, along with the timeline and language of the agreement, are positive. If the tie-up goes well, REM could set an industry standard and further build on Mobileye's competitive moat, Kwas tells investors. He keeps an Outperform rating on Mobileye shares, which are up 7.25% in afternoon trading.
02/13/17
RAJA
02/13/17
NO CHANGE
RAJA
Outperform
Mobileye deal with VW has longer-term value, says Raymond James
Raymond James analyst Tavis McCourt noted that Volkswagen's (VLKAY) partnership with Mobileye (MBLY) to use REM technology in its autonomous vehicles was announced back in early 2016, but only finalized today. While the pact has "no meaningful influence" near-term, it does have longer-term financial and strategic value for Mobileye, said McCourt, who keeps an Outperform rating on the shares.
02/13/17
JEFF
02/13/17
NO CHANGE
Target $52
JEFF
Buy
Jefferies says Mobileye agreement not unexpected, but important
Mobileye's (MBLY) agreement with Volkswagen (VLKAY) is not expected given the previously disclosed memorandum of understanding, but it is important nonetheless, Jefferies analyst David Kelley tells investors in a research note. The deal substantiates Mobileye's "strong" early positioning" in the integral segment of the "rapidly developing" autonomous vehicle sector, the analyst contends. He keeps a Buy rating on the shares with a $52 price target.
04/18/17
JEFF
04/18/17
UPGRADE
JEFF
Buy
Volkswagen upgraded to Buy from Underperform at Jefferies
Jefferies analyst Philippe Jean Houchois double upgraded Volkswagen to Buy from Underperform and raised his price target for the shares to EUR 160 from EUR 110.
C Citi
$66.72

-0.3 (-0.45%)

06/09/17
UBSW
06/09/17
UPGRADE
Target $64
UBSW
Neutral
Citi upgraded to Neutral from Sell at UBS
Citi analyst Saul Martinez upgraded Citi to Neutral and raised his price target for the shares to $64 from $58. The analyst sees an improved risk/reward at current share levels. Global growth "looks resilient," protectionist policies have not emerged, and the path forward for structural reforms in the U.S. "is not as clear," Martinez tells investors in a research note. He views Citi as an attractive capital return story.
06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
06/09/17
06/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying the company's in-game innovation, starting with Poker, is resulting in higher engagement and monetization. 2. Citi (C) upgraded to Neutral from Sell at UBS with analyst Saul Martinez saying he sees an improved risk/reward at current share levels. Global growth "looks resilient," protectionist policies have not emerged, and the path forward for structural reforms in the U.S. "is not as clear." 3. Comerica (CMA) upgraded to Outperform from Market Perform at FBR Capital. 4. Camping World (CWH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he expects growth to continue despite late-cycle concerns. 5. Humana (HUM) upgraded to Buy from Hold at Argus with analyst David Toung saying he is upbeat about its growth outlook following the termination of its merger deal with Aetna (AET). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/17
FBCO
07/17/17
NO CHANGE
Target $72
FBCO
Outperform
Citi price target raised to $72 from $64 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Citi to $72 from $64 following a better than expected Q2. The analyst reiterates an Outperform rating on the shares.
KKR KKR
$19.25

0.09 (0.47%)

05/09/17
PIPR
05/09/17
NO CHANGE
Target $18
PIPR
Overweight
Pandora sale path accelerated with KKR investment, says Piper Jaffray
Piper Jaffray analyst Stan Meyers believes Pandora's (P) path towards a potential sale has accelerated following KKR's (KKR) strategic investment. The analyst also expects Pandora's margins in its core radio business to continue improving. He remains "upbeat" on the shares with an Overweight rating and $18 price target.
04/17/17
04/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) was downgraded to Equal Weight from Overweight at Morgan Stanley and to Underperform from Market Perform at BMO Capital. 2. Incyte (INCY) downgraded to Neutral from Overweight at Piper Jaffray with analyst Joshua Schimmer citing the complete response letter from the FDA for baricitinib, indicating a need to determine appropriate doses. This setback could take years and lead to approval of only the lower dose, leaving potentially little differentiation from Pfizer's (PFE) rheumatoid arthritis treatment Xeljanz," Schimmer tells investors in a research note. The analyst prefers to wait for a "cleaner entry point" into the shares. 3. KKR (KKR) downgraded to Neutral from Buy at Citi with analyst William Katz saying he views the stock's valuation relative to peers as less attractive at current levels. 4. Monster Beverage (MNST) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Judy Hong saying she expects shares to be range-bound near-term due to soft core Monster sales trends in the US. 5. PNC Financial (PNC) downgraded to Hold from Buy at Rafferty Capital with analyst Richard Bove saying bank stock valuations are too high and growth is lacking. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/17
SBSH
04/17/17
DOWNGRADE
Target $19
SBSH
Neutral
KKR downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded KKR to Neutral and lowered his price target for the shares to $19 from $20.50. The analyst views the stock's valuation relative to peers as less attractive at current levels.
05/09/17
NEED
05/09/17
NO CHANGE
Target $16
NEED
Buy
KKR adds $5 per share to Pandora value, says Needham
Noting that Pandora (P) announced it had raised $150M by selling a 5-year, 8% convertible preferred security to KKR (KKR), Needham analyst Laura Martin calculates that adding KKR to the Pandora story adds $5 per share to the latter's value, implying that it should trade up to $15 per share on the news over time. The analyst believes KKR provides a financial safety net, and expects KKR's exit time frame to be 5 years, giving public shareholders a clearer exit path. She reiterates a Buy rating and $16 price target on Pandora's shares.
CG Carlyle Group
$20.40

0.15 (0.74%)

06/08/17
BOFA
06/08/17
UPGRADE
BOFA
Buy
Carlyle Group upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier upgraded Carlyle Group (CG) to Buy saying the outlook for alternative asset managers is improving following a challenging 2015 and 2016. The analyst highlights "healthy" fundraising, improving returns, and rising distributions for the space. Carrier raised his price target for Carlyle to $21 from $20 while noting that Apollo Global (APO) remains his top pick in the space.
05/11/17
FBCO
05/11/17
UPGRADE
Target $23
FBCO
Outperform
Carlyle Group upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Craig Siegenthaler upgraded Carlyle Group to Outperform and maintained a $23 price target. The analyst believes fee-related earnings could expand by 2-3x by 2019-20 as fundraising accelerates, accrued investments generate sizable returns, and sees significant valuation expansion as fundamentals improved.
05/04/17
05/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Buy from Neutral at BofA/Merrill with analyst Krish Sankar saying First Solar's execution has improved and said the low cost Series 6 product could lead to better margins starting in the second quarter of 2018. Sankar also told investors First Solar's valuation is attractive and the balance sheet has strengthened. 2. Fogo De Chao (FOGO) upgraded to Buy from Hold at Canaccord with analyst Lynne Collier saying she sees an improved outlook for the overall industry in the next 12-24 months and she has increased confidence in the company's ability to drive market share gains. Collier raised her price target to $20 from $16 on Fogo de Chao shares. 3. Carlyle Group (CG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee citing the "strong" first quarter results and accrued carry. 4. Regions Financial (RF) upgraded to Buy from Neutral at BofA/Merrill with analyst Erika Najarian saying the market is undervaluing a "significant capital return story" following the year-to-date underperformance relative to peers. The analyst sees upside to the dividend and thinks Regions can return 20% of its market capitalization over the next two years. Her price target of $17 implies 20% upside from current levels. 5. Bunge (BG) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan citing a balanced risk/reward following the 11% post-earnings selloff. The analyst keeps a $70 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/04/17
KBWI
05/04/17
UPGRADE
Target $23
KBWI
Outperform
Carlyle Group upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee upgraded Carlyle Group to Outperform and raised his price target for the shares to $23 from $17.50 citing the "strong" Q1 results and accrued carry.
KWHIY Kawasaki Heavy Industries

MTU Mitsubishi UFJ
$6.40

-0.09 (-1.39%)

11/29/16
UBSW
11/29/16
DOWNGRADE
UBSW
Neutral
Mitsubishi UFJ downgraded to Neutral from Buy at UBS
02/21/17
SBSH
02/21/17
UPGRADE
SBSH
Buy
Mitsubishi UFJ upgraded to Buy from Neutral at Citi
02/28/17
MZHO
02/28/17
UPGRADE
MZHO
Buy
Mitsubishi UFJ upgraded to Buy from Neutral at Mizuho
04/21/17
LYON
04/21/17
UPGRADE
LYON
Buy
Mitsubishi UFJ upgraded to Buy from Outperform at CLSA

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$242.41

3.88 (1.63%)

07:37
10/17/17
10/17
07:37
10/17/17
07:37
Earnings
Goldman Sachs reports Q3 EPS $5.02, consensus $4.17 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:37
10/17/17
10/17
07:37
10/17/17
07:37
Hot Stocks
Impax, Amneal combination expected to be accretive to Impax EPS in first year »

On a pro forma basis, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

TEAR

TearLab

$1.36

-0.06 (-4.23%)

07:35
10/17/17
10/17
07:35
10/17/17
07:35
Hot Stocks
TearLab to pursue initial FDA clearance of test card measuring MMP-9 »

TearLab provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$50.55

-1 (-1.94%)

07:35
10/17/17
10/17
07:35
10/17/17
07:35
Hot Stocks
Eagle Pharmaceuticals announces new patent for RYANODEX »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

VRX

Valeant

$12.92

-0.47 (-3.51%)

, RIG

Transocean

$11.05

0.19 (1.75%)

07:35
10/17/17
10/17
07:35
10/17/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

VRX

Valeant

$12.92

-0.47 (-3.51%)

RIG

Transocean

$11.05

0.19 (1.75%)

TMUS

T-Mobile

$60.97

-0.42 (-0.68%)

HIMX

Himax

$9.14

-0.19 (-2.04%)

RRC

Range Resources

$19.51

0.07 (0.36%)

RTN

Raytheon

$188.71

0.82 (0.44%)

BKD

Brookdale Senior Living

$10.12

0.02 (0.20%)

OLN

Olin

$35.46

-0.08 (-0.23%)

UPL

Ultra Petroleum

$8.15

0.04 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 16

    Nov

CP

Canadian Pacific

$168.46

-0.09 (-0.05%)

, CSX

CSX

$52.84

0.01 (0.02%)

07:34
10/17/17
10/17
07:34
10/17/17
07:34
Recommendations
Canadian Pacific, CSX, Norfolk Southern, Genesee & Wyoming, Canadian National analyst commentary  »

Railroad estimates…

CP

Canadian Pacific

$168.46

-0.09 (-0.05%)

CSX

CSX

$52.84

0.01 (0.02%)

NSC

Norfolk Southern

$129.80

-1.85 (-1.41%)

GWR

Genesee & Wyoming

$71.39

-0.48 (-0.67%)

CNI

Canadian National

$80.23

-0.56 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 09

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:34
10/17/17
10/17
07:34
10/17/17
07:34
Hot Stocks
Impax, Amneal Pharmaceuticals to merge in all-stock transaction »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

KBSTY

Kobe Steel

$3.68

0.13 (3.66%)

, GM

General Motors

$45.76

-0.12 (-0.26%)

07:34
10/17/17
10/17
07:34
10/17/17
07:34
Periodicals
U.S. DOJ requests information on Kobe Steel metal scandal, WSJ says »

The U.S. Justice…

KBSTY

Kobe Steel

$3.68

0.13 (3.66%)

GM

General Motors

$45.76

-0.12 (-0.26%)

TM

Toyota

$123.42

0.04 (0.03%)

BA

Boeing

$259.75

-0.99 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

PRTA

Prothena

$60.32

-0.43 (-0.71%)

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Conference/Events
Prothena management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

HK

Halcon Resources

$5.90

-0.1 (-1.67%)

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Upgrade
Halcon Resources rating change  »

Halcon Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 15

    May

  • 16

    May

ARMK

Aramark

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Recommendations
Aramark analyst commentary  »

Aramark price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

MDXG

MiMedx

$13.51

0.31 (2.35%)

07:32
10/17/17
10/17
07:32
10/17/17
07:32
Hot Stocks
MiMedx notified by FDA to proceed with Phase 2B IND trial for osteoarthritis »

MiMedx has been notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax, Amneal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JBL

Jabil Circuit

$28.61

0.37 (1.31%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Recommendations
Jabil Circuit analyst commentary  »

Jabil Circuit strength in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTCY

Evotec

$51.15

2.3099 (4.73%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Conference/Events
Evotec management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

CARB

Carbonite

$22.30

-0.5 (-2.19%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Initiation
Carbonite initiated  »

Carbonite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NEWS

NewStar Financial

$12.13

0.23 (1.93%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Hot Stocks
Breaking Hot Stocks news story on NewStar Financial »

NewStar Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JRVR

James River Group

$41.95

-0.08 (-0.19%)

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Initiation
James River Group initiated  »

James River Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

MDB

MongoDB

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Syndicate
MongoDB IPO deal range increased to $20.00-$22.00 »

MongoDB 's 8M share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

$202.68

3.19 (1.60%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PSX

Phillips 66

$90.87

-3.56 (-3.77%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Phillips 66 analyst commentary  »

Phillips 66 price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

VZ

Verizon

$48.09

0.23 (0.48%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Periodicals
Verizon FiOS stops carrying Univision, WSJ reports »

Verizon FiOS has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

VLO

Valero

$77.42

-0.66 (-0.85%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Recommendations
Valero analyst commentary  »

Valero price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SNDX

Syndax

$12.76

0.39 (3.15%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Syndicate
Syndax raises $25M in a registered direct offering »

Syndax announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.